The CYB5R3 T117S variant reduces riociguat efficacy by impairing nitric oxide signaling in sickle cell disease patients.
- Open access
Moving in bioRxiv, Blood, Frontiers in Genetics, Photosynthesis Research.
Rebuilt
Nothing in this area has moved yet this week.
Newest first · last 60 days
The CYB5R3 T117S variant reduces riociguat efficacy by impairing nitric oxide signaling in sickle cell disease patients.
Persistent hyperhomocysteinemia in an adolescent with celiac disease and homozygous MTHFR c.665C>T polymorphism was significantly reduced by targeted vitamin therapy.
Chlorophyll-c molecules in photosynthetic complexes predominantly coordinate from the β-side, contrasting with the α-ligation preference of other (B)Chls, with 24 of 42 molecules showing this trait.
Journals this month
Moving areas, week to 3 Oct 2026